100 related articles for article (PubMed ID: 21959589)
1. Interaction of C1 inhibitor with thrombin on the endothelial surface.
Caccia S; Castelli R; Maiocchi D; Bergamaschini L; Cugno M
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):571-5. PubMed ID: 21959589
[TBL] [Abstract][Full Text] [Related]
2. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2.
Peterson EA; Sutherland MR; Nesheim ME; Pryzdial EL
J Cell Sci; 2003 Jun; 116(Pt 12):2399-408. PubMed ID: 12724354
[TBL] [Abstract][Full Text] [Related]
3. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
[TBL] [Abstract][Full Text] [Related]
5. Specific heparin fractions suppress endothelin-1 production in cultured human umbilical vein endothelial cells.
Reantragoon S; Arrigo LM; Seoud MM; Dweck HS; Rosenfeld L
Arch Biochem Biophys; 1994 Nov; 314(2):315-22. PubMed ID: 7979371
[TBL] [Abstract][Full Text] [Related]
6. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
Chang YS; Munn LL; Hillsley MV; Dull RO; Yuan J; Lakshminarayanan S; Gardner TW; Jain RK; Tarbell JM
Microvasc Res; 2000 Mar; 59(2):265-77. PubMed ID: 10684732
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular permeability of the cleaved reactive center loop within the carboxyl-terminal domain of C1 inhibitor.
Cheng ZD; Liu MY; Chen G; Zhang HM; Qin GJ; Liang G; Liu DX
Mol Immunol; 2008 Mar; 45(6):1743-51. PubMed ID: 18022239
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
[TBL] [Abstract][Full Text] [Related]
9. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
[TBL] [Abstract][Full Text] [Related]
10. Metabolic responses induced by thrombin in human umbilical vein endothelial cells.
Fan Y; Wu DZ; Gong YQ; Xu R; Hu ZB
Biochem Biophys Res Commun; 2002 May; 293(3):979-85. PubMed ID: 12051756
[TBL] [Abstract][Full Text] [Related]
11. Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration.
Drake WT; Lopes NN; Fenton JW; Issekutz AC
Lab Invest; 1992 Nov; 67(5):617-27. PubMed ID: 1434539
[TBL] [Abstract][Full Text] [Related]
12. In vitro interaction of C1-inhibitor with thrombin.
Cugno M; Bos I; Lubbers Y; Hack CE; Agostoni A
Blood Coagul Fibrinolysis; 2001 Jun; 12(4):253-60. PubMed ID: 11460008
[TBL] [Abstract][Full Text] [Related]
13. Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism.
Gabazza EC; Hayashi T; Ido M; Adachi Y; Suzuki K
Clin Sci (Lond); 2002 Feb; 102(2):167-75. PubMed ID: 11834136
[TBL] [Abstract][Full Text] [Related]
14. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
15. Vascular repair utilising immobilised heparin conjugate for protection against early activation of inflammation and coagulation.
Nordling S; Hong J; Fromell K; Edin F; Brännström J; Larsson R; Nilsson B; Magnusson PU
Thromb Haemost; 2015 Jun; 113(6):1312-22. PubMed ID: 25740465
[TBL] [Abstract][Full Text] [Related]
16. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
Martinez-Sales V; Vila V; Réganon E; Oms JG; Aznar J
Haematologica; 2003 Jun; 88(6):694-9. PubMed ID: 12801846
[TBL] [Abstract][Full Text] [Related]
17. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
[TBL] [Abstract][Full Text] [Related]
18. Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.
Séguin C; Abid MR; Spokes KC; Aird WC
Endothelium; 2008; 15(3):143-8. PubMed ID: 18568955
[TBL] [Abstract][Full Text] [Related]
19. Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells.
Yokokawa K; Tahara H; Kohno M; Mandal AK; Yanagisawa M; Takeda T
J Clin Invest; 1993 Oct; 92(4):2080-5. PubMed ID: 8408661
[TBL] [Abstract][Full Text] [Related]
20. The suppression of the coagulation of nonanticoagulated whole blood in vitro by human umbilical endothelial cells cultivated on microcarriers is not dependent on protein C activation.
Kohler HP; Müller M; Bombeli T; Straub PW; Haeberli A
Thromb Haemost; 1995 Apr; 73(4):719-24. PubMed ID: 7495085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
